Covid-19 Sentry

Contents

From Preprints

  1. the heterogeneity in disease transmission and outcomes for faculty/staff and students based on vaccination status and level of natural immunity; and (ii) variant- and dose-dependent vaccine efficacy. Using the Spring 2022 academic semester as a case study, we study various routine screening strategies, and find that screening the faculty/staff less frequently than the students, and/or the boosted and vaccinated less frequently than the unvaccinated, may avert a higher number of infections per test, compared to universal screening of the entire population at a common frequency. We also discuss key policy issues, including the need to revisit the mitigation objective over time, effective strategies that are informed by booster coverage, and if and when screening alone can compensate for low booster coverage.

    🖺 Full Text HTML: Screening for safe opening of universities under Omicron and Delta variants of COVID-19: When less is more
  1. The incentive accounted for 6,476-10,874 additional first vaccine doses from November 1-27, 2021, or 8.31-13.95% of all doses administered to those aged ≥60 years during that period. This result is robust to the inclusion of controls for the number of active vaccine delivery sites and for the nationwide Vooma weekend initiative (November 12-14), both of which also increased vaccinations through expanded access to vaccines and demand creation activities. Conclusions/Relevance: Financial incentives for COVID-19 vaccination led to a modest increase in first dose vaccinations among older adults in South Africa. In addition to financial incentives, expanded access to vaccines may also results in higher vaccination coverage.

    🖺 Full Text HTML: A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa
🖺 Full Text HTML: Fertility recovery despite the COVID-19 pandemic in Finland?

From Clinical Trials

From PubMed

  1. Older people have been disproportionately affected by the disease, as they have greater risk of hospitalization, are more vulnerable to severe infection, and have higher mortality than younger patients. Although effective vaccines have been rapidly developed…

From Patent Search